181 related articles for article (PubMed ID: 30816446)
1. Co‑expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis.
Liu J; Liu Q; Wang Y; Liu M; Qi Y; Gao J; Lin B
Int J Mol Med; 2019 Apr; 43(4):1687-1698. PubMed ID: 30816446
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance.
Gao J; Hu Z; Liu J; Liu D; Wang Y; Cai M; Zhang D; Tan M; Lin B
Med Oncol; 2014 May; 31(5):920. PubMed ID: 24692145
[TBL] [Abstract][Full Text] [Related]
3. The stimulation of IGF-1R expression by Lewis(y) antigen provides a powerful development mechanism of epithelial ovarian carcinoma.
Liu D; Liu J; Wang C; Lin B; Liu Q; Hao Y; Zhang S; Iwamori M
Int J Mol Sci; 2011; 12(10):6781-95. PubMed ID: 22072919
[TBL] [Abstract][Full Text] [Related]
4. The fucosylated CD147 enhances the autophagy in epithelial ovarian cancer cells.
Hu Z; Cai M; Deng L; Zhu L; Gao J; Tan M; Liu J; Lin B
Oncotarget; 2016 Dec; 7(50):82921-82932. PubMed ID: 27863372
[TBL] [Abstract][Full Text] [Related]
5. High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.
Zhu L; Feng H; Jin S; Tan M; Gao S; Zhuang H; Hu Z; Wang H; Song Z; Lin B
Tumour Biol; 2017 Jul; 39(7):1010428317711655. PubMed ID: 28671040
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma.
Zhuang H; Gao J; Hu Z; Liu J; Liu D; Lin B
PLoS One; 2013; 8(7):e68994. PubMed ID: 23894390
[TBL] [Abstract][Full Text] [Related]
7. Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma.
Wang ST; Liu JJ; Wang CZ; Lin B; Hao YY; Wang YF; Gao S; Qi Y; Zhang SL; Iwamori M
Oncol Rep; 2012 Apr; 27(4):1065-71. PubMed ID: 22138668
[TBL] [Abstract][Full Text] [Related]
8. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
[TBL] [Abstract][Full Text] [Related]
9. Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway.
Liu J; Lin B; Hao Y; Qi Y; Zhu L; Li F; Liu D; Cong J; Zhang S; Iwamori M
J Exp Clin Cancer Res; 2009 Dec; 28(1):154. PubMed ID: 20003467
[TBL] [Abstract][Full Text] [Related]
10. Study on the expression and clinical significances of lewis y antigen and integrin αv, β3 in epithelial ovarian tumors.
Wang Y; Liu J; Lin B; Wang C; Li Q; Liu S; Yan L; Zhang S; Iwamori M
Int J Mol Sci; 2011; 12(6):3409-21. PubMed ID: 21747684
[TBL] [Abstract][Full Text] [Related]
11. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
12. The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them.
Zhuang H; Tan M; Liu J; Li X; Gao J; Hu Z; Deng L; Zhu L; Lin B
Tumour Biol; 2015 Apr; 36(4):2343-9. PubMed ID: 25416440
[TBL] [Abstract][Full Text] [Related]
13. Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.
Zhu LC; Gao J; Hu ZH; Schwab CL; Zhuang HY; Tan MZ; Yan LM; Liu JJ; Zhang DY; Lin B
Am J Cancer Res; 2015; 5(2):830-43. PubMed ID: 25973320
[TBL] [Abstract][Full Text] [Related]
14. Lewis y antigen is expressed in oral squamous cell carcinoma cell lines and tissues, but disappears in the invasive regions leading to the enhanced malignant properties irrespective of sialyl-Lewis x.
Hotta H; Hamamura K; Yamashita K; Shibuya H; Tokuda N; Hashimoto N; Furukawa K; Yamamoto N; Hattori H; Toyokuni S; Ueda M; Furukawa K
Glycoconj J; 2013 Aug; 30(6):585-97. PubMed ID: 23242548
[TBL] [Abstract][Full Text] [Related]
15. Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers.
Zhang D; Gao J; Zhu L; Hu Z; Hou R; Liu S; Tan M; Liu J; Lin B
Int J Mol Sci; 2013 May; 14(6):11024-33. PubMed ID: 23708102
[TBL] [Abstract][Full Text] [Related]
16. c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer.
Hao Y; Zhu L; Yan L; Liu J; Liu D; Gao N; Tan M; Gao S; Lin B
Oncol Rep; 2017 Dec; 38(6):3355-3366. PubMed ID: 29130097
[TBL] [Abstract][Full Text] [Related]
17. Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and its correlation with poor prognosis.
Gou X; Chen H; Jin F; Wu W; Li Y; Long J; Gong X; Luo M; Bi T; Li Z; He Q
Pathol Oncol Res; 2014 Apr; 20(2):475-81. PubMed ID: 24357157
[TBL] [Abstract][Full Text] [Related]
18. Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer.
Liu J; Zheng M; Qi Y; Wang H; Liu M; Liu Q; Lin B
Int J Oncol; 2018 Oct; 53(4):1774-1786. PubMed ID: 30066907
[TBL] [Abstract][Full Text] [Related]
19. Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen.
Zhang F; Liu J; Lin B; Liu Q; Zhao Y; Zhu L; Hao Y; Zhang S; Iwamori M
Int J Mol Sci; 2011; 12(11):7323-34. PubMed ID: 22174601
[TBL] [Abstract][Full Text] [Related]
20. Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I.
Gao L; Yan L; Lin B; Gao J; Liang X; Wang Y; Liu J; Zhang S; Iwamori M
J Exp Clin Cancer Res; 2011 Feb; 30(1):15. PubMed ID: 21294926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]